ChemotherapyThe use of systemic therapy in head and neck cancer has expanded in the last few years. Chemotherapy, in combination with radiotherapy, is now the standard of care for patients with locally advanced disease, either as a primary treatment or after surgical resection.
Targeted therapies have improved the efficacy of conventional chemotherapy and in some cases are used alone as a monotherapy.
The highest quality multidisciplinary care uses systemic therapy as an integral part of head and neck cancer care. Every patient requiring systemic therapy at SCCA has the option of receiving the standard of care or participating in innovative clinical studies that explore new approaches to fight their disease.
At SCCA, we have the facility, equipment, staff, and expertise that are among the best in the world. We believe that we can make a difference in the lives of head and neck cancer patients.